Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Nanoviricides, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 27 | 30 | +3 |
| Shares | 1.23M | 1.20M | −30.9K (−2.5%) |
| Value | $1.42M | $1.61M | +$193.4K (+13.6%) |
New holders (7)
Institutions that held Nanoviricides, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Royal Bank of Canada | 30,535 | $41.0K | 0.00% |
| Moss Adams Wealth Advisors LLC | 12,000 | $16.1K | 0.01% |
| XTX Topco Ltd | 10,214 | $13.7K | 0.00% |
| NBC Securities, Inc. | 3,400 | $4.00K | 0.00% |
| UBS Group AG | 583 | $781 | 0.00% |
| Flaharty Asset Management, LLC | 200 | $268 | 0.00% |
| JPMorgan Chase & Co | 13 | $17 | 0.00% |
Sold out (4)
Institutions that held Nanoviricides, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Two Sigma Securities, LLC | 24,131 | $27.8K |
| Two Sigma Investments, LP | 19,865 | $22.8K |
| Simplex Trading, LLC | 2,964 | $3.00K |
| ICA Group Wealth Management, LLC | 200 | $230 |